Abscess - Ithumbahttps://en.wikipedia.org/wiki/Abscess
I- Ithumba (Abscess) yingqokelela yobovu obukheke ngaphakathi kwezicubu zomzimba. Imiphumo kunye neempawu zamathumba ziquka ububomvu, intlungu, ukufudumala, kunye nokudumba. Ukudumba kunokuziva kugcwele ulwelo xa ucinezelwe. Ummandla obomvu udla ngokudlulela ngaphaya kwendawo yokuvuvukala.

Ngokuqhelekileyo zibangelwa lusulelo lwebhaktheriya. Eyona bhaktheriya ixhaphakileyo ekhoyo yi-methicillin-resistant Staphylococcus aureus. Ukuxilongwa kwethumba lesikhumba ngokuqhelekileyo kwenziwa ngokusekelwe kwindlela elikhangeleka ngayo, kwaye kuqinisekiswa ngokusikwa ukuba sivule. Ukuskena nge-Ultrasound imaging kunokuba luncedo kwiimeko apho ukuxilongwa kungacacanga. Kumathumba ajikeleze i-anus, i-computer tomography (CT) inokubaluleka ekujongeni usulelo olunzulu.

Unyango olusemgangathweni kumathumba amaninzi esikhumba okanye amathumba athambileyo kwiithishu kukusikwa sivuleke, sikhuphe umphunga, ngelixa kusetyenziswa i-antibiotics. Ukufunxa ubovu ngenaliti akwanelanga.

Amathumba esikhumba axhaphakile kwaye sele exhaphake kakhulu kwiminyaka yakutshanje. Imiba yomngcipheko ibandakanya ukusetyenziswa kweziyobisi nge-intravenous, kunye namazinga aphakamileyo afikelela kwi-65% phakathi kwabasebenzisi. Ngo-2005 e-United States, abantu abangama-3.2 ezigidi baya kwisebe likaxakeka ukuze bafumane ithumba. e-Australia, malunga ne-13,000 yabantu balaliswa esibhedlele ngo-2008 ngale meko.

○ Unyango
Ukunyanga amathumba ngamachiza afumaneka ngaphandle kwekhawuntara kunzima kwiimeko ezininzi. Ukuba iimpawu ezinjengomkhuhlane kunye nokugodola zivela kuwo wonke umzimba, nceda uqhagamshelane nogqirha ngokukhawuleza.

☆ AI Dermatology — Free Service
Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
  • inflamed epidermal cyst. Indawo emnyama idityaniswa ne-i-cyst engaphantsi.
  • Kule meko yokuvuvukala kwezihlathi, kufuneka kuqwalaselwe ukuba kunokwenzeka i-cyst epidermal.
  • Uhlobo oluqatha lwe Ithumba (Abscess) lunokushiya isiva. I-erythema encinci ejikeleze isilonda ibonisa ukuba usulelo lusekho kwimeko yokusombulula.
  • Ithumba (Abscess) ― iintsuku ezintlanu emva kokusikwa kunye nokuphuma kwamanzi.
  • Ichaphaza elimnyama kwindawo ephezulu yethumba libonisa ukuba yi-epidermal cyst.
References Current Treatment Options for Acute Skin and Skin-structure Infections 30957166 
NIH
Abantu abaninzi baya kumagumbi ekuxakeka ngenxa yosulelo lwesikhumba olubangelwa ziibhaktheriya. Staphylococcus aureus yeyona ntsholongwane ephambili ebangela ezi zifo, kwaye kuya kuba nzima ukuyinyanga ngenxa yokuvela kwe community-associated methicillin-resistant Staphylococcus aureus (MRSA).
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
 Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus 32257966 
NIH
Staphylococcus aureus ihlukaniswa ibe ziindidi ezimbini ngokusekelwe kwimpendulo yazo kwi‑antibiotics: methicillin-sensitive Staphylococcus aureus (MSSA) kunye ne‑methicillin-resistant Staphylococcus aureus (MRSA). Kule minyaka edlulileyo, ngenxa yokuvela kwebhaktiriya kunye nokusetyenziswa ngokugqithisileyo kwamayeza okubulala iintsholongwane, ukuxhathisa kwe S. aureus kumachiza kuye kwenyuka, okukhokelela ekunyukeni kwamazinga e‑MRSA emhlabeni jikelele.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
 Treatment of severe skin and soft tissue infections: a review 29278528 
NIH
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.